Clinical trial · Observational
The Effect of Digital Breast Tomosynthesis in Breast Cancer Long-term Survival: a Single Institution Study
NCT05600257CI-TRIAL-00061947completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate whether digital breast tomosynthesis (DBT) benefits survival improvement.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DBT | Device | — | UNRESOLVED |
| DM | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Screening cohort
- description
- Women received mammography screening
- interventionNames
- Device: DBT
- Device: DM
- label
- Diagnostic cohort
- description
- Women received clinical breast examination
- interventionNames
- Device: DBT
- Device: DM
Primary outcomes (1)
- measure
- Overall survival rate
- timeFrame
- Up to 111 months
- description
- Compare the overall survival rate according to breast density type, cancer stage, mammography test type, and imaging modality.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 23 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: * individuals were diagnosed with breast cancer according to the International Disease Classification Criteria Exclusion Criteria: * no surgery or incomplete surgical pathology stage * complete remission after neoadjuvant chemotherapy * non-breast cancer death * bilateral breast cancer * male breast cancer * no pre-surgery mammography image
References
Publications (0)
Data not yet available
No reference posted for this study.